S32 — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
TwinStrand develops Duplex Sequencing technology, a genomic platform for improving accuracy in clinical medicine and life sciences research applications.
BiotechData & InfrastructureDeep TechMedical DevicesSeattle, US
Jesse Salk(Executive Officer, Director, Promoter)Kellie Bickel(Executive Officer)Elena Cant(Executive Officer)Karen Dabbs(Executive Officer)
BoardChad Waite(Director)Michael Pellini(Director)in
Board seatMike Pellini· per SEC Form D · $25.7M raise · filed Jun 2023
Co-investorsMadrona Venture Group
Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.
AI & Machine LearningBiotechMedical DevicesPalo Alto, US
Jakob Uszkoreit(Executive Officer, Director, Promoter)Kevin Heyries(Executive Officer)Diana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)
BoardVijay S. Pande(Director)in
Co-investorsAndreessen HorowitzArtis VenturesObvious VenturesSection 32NVentures
Puzzle builds a modern accounting system for startups and small-to-medium businesses, delivering real-time financial intelligence by reconstructing core ledger and data infrastructure.
AI & Machine LearningFintechSaaSSan Francisco, US
Sasha Orloff(Founder)inJohn Cwikla
BoardHEMANT TANEJA(Director)in
Co-investorsFelicis VenturesFjor FoundersKapor CapitalOn DeckSterling RoadTwo Culture Capital+3 more
Puzzle is a crypto wallet for the Aleo blockchain, available on iOS, Android, and Chrome, that includes a native Arcade offering earning opportunities to users.
Crypto & Web3Fintech
Co-investorsBain Capital CryptoFelicis VenturesGeneral CatalystKapor CapitalSterling Road
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.